Product Information
CLONAZEPAM 0.25 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4477 per EA under NDC 00093929167. Its NADAC has been published 221 times since Jun 1, 2022.
FDA first approved this application on Aug 10, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093929167
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077194FDA Approved
8/10/2005
TE Code
AB
On Market Since
3/2/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.25 MG ODT has been published 221 times since Jun 1, 2022, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4477 per EA |
|---|---|
| All-time high | $0.7486 (Aug 10, 2022) |
| All-time low | $0.3522 (Jan 17, 2024) |
| 52-week high | $0.6792 |
| 52-week low | $0.4331 |
| Median price | $0.5080 |
| Average price | $0.5314 |
| Largest weekly change | +52.3% (Feb 21, 2024) |
| Weeks tracked | 221 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clonazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.25 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.25 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $0.4477 per EA (NDC 00093929167), effective Aug 19, 2026.
How has the price of CLONAZEPAM 0.25 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.25 MG ODT has declined 36.3%. It has been tracked across 221 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.25 MG ODT?
Since Jun 1, 2022, the NADAC for CLONAZEPAM 0.25 MG ODT has ranged from a low of $0.3522 (Jan 17, 2024) to a high of $0.7486 (Aug 10, 2022), with a median of $0.5080 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.25 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of CLONAZEPAM 0.25 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLONAZEPAM 0.25 MG ODT?
CLONAZEPAM 0.25 MG ODT (NDC 00093929167) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.